StonvexLoading…
StonvexStonvexStonvexCore line items from AXP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $41.30B | $38.83B | $37.22B | $34.22B |
Operating Income | $13.79B | $12.89B | $10.51B | $9.59B |
Net Income | $10.83B | $10.13B | $8.37B | $7.51B |
EPS (Diluted) | $15.38 | $14.01 | $11.21 | $9.85 |
Total Assets | $300.05B | $271.46B | $261.11B | $228.35B |
Total Liabilities | $266.58B | $241.20B | $233.05B | $203.64B |
Cash & Equivalents | $47.79B | $40.64B | $46.60B | $33.91B |
Free Cash Flow OCF − CapEx | $16.00B | $12.14B | $17.00B | $19.22B |
Shares Outstanding | 686.00M | 702.00M | 723.00M | 743.00M |